CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

SILVERARC CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001816307)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 50,000 Value ($000) $2,083 Avg Close $31.97 Range $25.83 - $47.41
Q1 2024
Shares 127,835 Value ($000) $5,984 Avg Close $39.13 Range $33.67 - $47.58
Q3 2023
Shares 220,000 Value ($000) $6,543 Avg Close $20.61 Range $15.76 - $31.00
Q4 2022
Shares 152,747 Value ($000) $2,795 Avg Close $17.62 Range $15.37 - $19.97
Q3 2022
Shares 149,027 Value ($000) $2,927 Avg Close $20.39 Range $17.79 - $22.85
Q2 2022
Shares 139,539 Value ($000) $2,602 Avg Close $19.96 Range $15.91 - $27.86
Q1 2022
Shares 114,004 Value ($000) $2,502 Avg Close $20.24 Range $16.53 - $28.95
Q4 2021
Shares 111,860 Value ($000) $3,178 Avg Close $24.65 Range $18.97 - $28.82
Q3 2021
Shares 49,382 Value ($000) $1,039 Avg Close $20.92 Range $16.68 - $25.50